Comments

Sarepta Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Sarepta Therapeutics (SRPT) operate in?

Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SRPTNASDAQ

Sarepta Therapeutics (SRPT) Forecast

News Earnings Sarepta Therapeutics (SRPT) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Sarepta Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:SRPT | Benzinga

Explore Sarepta Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SRPT.

Open	$37.85
Close	-
Volume / Avg.	549.67K / 3.54M
Day Range	$37.47 - $39.01
52 Wk Range	34.10 - 173.25
Market Cap	$3.75B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	10.52%
Days to Cover	1.22

Recent News

Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn't Ignore

Investors searching for high-quality opportunities in the pharmaceutical space should keep a close eye on stocks trading at extremely oversold levels. One of the most popular ways to measure this is through the

MarketBeat

Ten-Year Data From Roche's Breast Cancer Trial Shows Perjeta-Based Regimen Cuts Death Risk By 17%

Roche's APHINITY study shows promising results for HER2-positive breast cancer treatment with Perjeta regime

Vandana Singh

Benzinga Bulls And Bears: IBM, Novavax, Arm Holdings — And UK Trade Deal Boosts Markets

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Benzinga Senior Editor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$37.85
Close	-
Volume / Avg.	549.67K / 3.54M
Day Range	$37.47 - $39.01
52 Wk Range	34.10 - 173.25
Market Cap	$3.75B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	10.52%
Days to Cover	1.22

About Sarepta Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Sarepta Therapeutics (SRPT) stock?

You can purchase shares of Sarepta Therapeutics (NASDAQ:SRPT) through any online brokerage.

View our list of the best stock brokerages

Who are Sarepta Therapeutics (SRPT) competitors?

Other companies in Sarepta Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).

What is the forecast, or price target, for Sarepta Therapeutics (SRPT) stock?

Sarepta Therapeutics has a consensus price target of $133.89.

What is the current price for Sarepta Therapeutics (SRPT)?

The stock price for Sarepta Therapeutics (NASDAQ: SRPT) is $38.19 last updated June 2, 2025 at 11:06 AM EDT.

Does Sarepta Therapeutics (SRPT) pay a dividend?

There are no upcoming dividends for Sarepta Therapeutics.

When is Sarepta Therapeutics (NASDAQ:SRPT) reporting earnings?

Sarepta Therapeutics’s Q2 earnings are confirmed for Wednesday, August 6, 2025.

Is Sarepta Therapeutics (SRPT) going to split?

There is no upcoming split for Sarepta Therapeutics.

What sector and industry does Sarepta Therapeutics (SRPT) operate in?

Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.